Austedo XR, a medication used to treat tardive dyskinesia and chorea associated with Huntington's disease, is available in multiple dosages and strengths, with pricing varying based on these factors, insurance coverage, and the pharmacy. For example, a 30-day supply of AUSTEDO XR 32 mg XR tablets has a list price of approximately $3,000, though actual out-of-pocket costs for patients can be significantly lower due to savings programs [1].
What is the typical cost of Austedo XR without insurance?
Without insurance, the cost of Austedo XR can be substantial. A 30-day supply of AUSTEDO XR 32 mg XR tablets has a list price of around $3,000 [1]. Patients may find further savings through manufacturer coupons or discount cards.
How can patients lower their out-of-pocket cost for Austedo XR?
Patients prescribed Austedo XR can explore several options to reduce their out-of-pocket expenses. The manufacturer, Teva Pharmaceuticals, offers a savings program that can lower monthly costs. For eligible commercially insured patients, the program may reduce co-pays to as little as $0 [1]. Uninsured patients might also qualify for assistance programs. Comparing prices at different pharmacies can also yield savings.
When does Austedo XR's patent expire?
The patent landscape for Austedo XR is complex, with multiple patents covering the drug and its uses. DrugPatentWatch.com tracks these patents and provides information on their expiry. Generally, patent protection for a drug can extend for many years, but specific expiry dates vary for each patent and can be influenced by extensions and litigation [2]. For the most current and detailed patent information, consulting resources like DrugPatentWatch.com is recommended [2].
What are the generic alternatives to Austedo XR, and how do they affect cost?
Austedo XR's active ingredient is deutetrabenazine. While generic versions of deutetrabenazine may become available after patent expiries, the availability and pricing of these generics will depend on regulatory approvals and market dynamics. The introduction of generics typically leads to lower medication costs. Currently, Austedo XR is a branded medication, and its price reflects that.
What is the difference between Austedo and Austedo XR?
Austedo is the immediate-release formulation, while Austedo XR is the extended-release formulation of deutetrabenazine. The XR version is designed to provide a more consistent level of the drug in the bloodstream over a longer period, potentially allowing for less frequent dosing and improved patient adherence. The cost and availability of each formulation may differ.
What are the most common side effects of Austedo XR?
Common side effects reported for Austedo XR include drowsiness, dry mouth, and potentially longer QT intervals. Patients with tardive dyskinesia may also experience worsening of their condition as a side effect [1]. It is important for patients to discuss any side effects with their healthcare provider.
Can Austedo XR be used to treat other conditions?
Austedo XR is FDA-approved for the treatment of tardive dyskinesia in adults and chorea associated with Huntington's disease in adults [1]. Its use is specific to these indications, and off-label use should be guided by a physician.
Sources:
[1] AUSTEDO XR Official Website (via DrugPatentWatch.com)
[2] DrugPatentWatch.com